The Global Clinical Trial Imaging Market is expected to grow at a rate of 8% by 2026. Growing number of biotechnology & pharmaceutical firms and Contract Research Organizations (CROs), increasing R&D ...

Vincent Medical Holdings, a Hong Kong-based medical device maker, has doubled down on manufacturing in China by investing in ...

If you used Depo-Provera birth control for over a year, it’s important to pursue a meningioma or brain tumor diagnosis if you ...

Scientists have found a way to boost the brain's system to clear waste from the organ in mice, which could open treatment ...

Finnish startup AIATELLA has raised €2m ($2.27m) in financing to develop and scale its cardiovascular imaging technology ...

At the meeting, Qiu received the Prince-Meaney Translational Science Award, an honor that is part of the ISMRM Young ...

With China tightening rare earth exports, Indian firms eye domestic incentives and stockpiling, as global automakers and ...

This is then supplemented by smaller studies as needed. The use of gold standard magnetic resonance imaging data was preferentially included over other imaging modalities such as echocardiography for ...

Bayer seeks Japanese marketing authorization for low-dose contrast agent, gadoquatrane for contrast-enhanced MRI of all body regions and CNS: Berlin Tuesday, June 3, 2025, 13:00 H ...

XENOVIEW™, prepared from the Xenon Xe 129 Gas Blend, is a hyperpolarized contrast agent indicated for use with magnetic resonance imaging (MRI) for evaluation of lung ventilation in adults and ...

LONDON, GREATER LONDON, UNITED KINGDOM, May 30, 2025 /EINPresswire.com/ -- The Business Research Company’s Latest Report Explores Market Driver, Trends, Regional Insights - Market Sizing & Forecasts ...

Non-invasive cardiovascular imaging has revolutionized the diagnosis and management ... alongside evaluations of mechanical support devices. o Clinical Management and Outcomes: Develop and disseminate ...